| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | -13.2% | +6.8% |
| R&D Expense | $610K | +11.5% | +2.8% |
| SG&A Expense | $502K | -20.1% | -33.8% |
| Operating Income | -$132K | -166.6% | +80.6% |
| Pre-tax Income | -$914K | -55.3% | +37.8% |
| Income Tax | $0 | — | — |
| Net Income | -$914K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.7M | -1.8% | +23.6% |
| Accounts Receivable | $1.0M | -30.8% | +5.2% |
| Inventory | $426K | +16.8% | +34.1% |
| Current Assets | $3.5M | -11.8% | +14.2% |
| Total Assets | $5.0M | -9.9% | +20.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.0M | — | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$61K | — | — |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | $1.0M | — | — |
| +37.8% |
| EPS (Basic) | $0.00 | — | — |
| $46.3M |
| +0.3% |
| +6.8% |
| Total Liabilities | $47.4M | +0.5% | +8.5% |
| Stockholders' Equity | -$42.4M | -1.8% | -7.3% |